Sivik Global Healthcare LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 33.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 40,000 shares of the company’s stock after selling 20,000 shares during the quarter. Sivik Global Healthcare LLC’s holdings in Cardinal Health were worth $4,032,000 as of its most recent filing with the SEC.
Other institutional investors also recently added to or reduced their stakes in the company. Cornerstone Planning Group LLC bought a new position in shares of Cardinal Health in the 3rd quarter worth $26,000. BKM Wealth Management LLC acquired a new position in Cardinal Health in the fourth quarter valued at about $30,000. Wetzel Investment Advisors Inc. acquired a new stake in Cardinal Health in the fourth quarter valued at about $36,000. Headlands Technologies LLC bought a new position in Cardinal Health in the third quarter valued at about $47,000. Finally, McGlone Suttner Wealth Management Inc. bought a new position in Cardinal Health during the 4th quarter worth $59,000. 87.17% of the stock is owned by institutional investors and hedge funds.
Cardinal Health Stock Performance
Shares of NYSE:CAH traded up $0.12 on Tuesday, reaching $103.03. The company’s stock had a trading volume of 2,456,082 shares, compared to its average volume of 2,250,772. The company has a market cap of $25.06 billion, a P/E ratio of 40.57, a PEG ratio of 1.04 and a beta of 0.68. Cardinal Health, Inc. has a 52-week low of $77.56 and a 52-week high of $116.04. The company has a 50-day simple moving average of $109.48 and a 200 day simple moving average of $104.93.
Cardinal Health Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a $0.5006 dividend. The ex-dividend date was Thursday, March 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.94%. Cardinal Health’s payout ratio is 78.74%.
Wall Street Analyst Weigh In
A number of analysts have commented on the stock. Wells Fargo & Company cut their price target on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating on the stock in a research report on Monday. Barclays initiated coverage on Cardinal Health in a research note on Wednesday, January 3rd. They set an “overweight” rating and a $117.00 price target for the company. SVB Leerink assumed coverage on Cardinal Health in a report on Monday, February 26th. They issued an “outperform” rating and a $125.00 target price for the company. Leerink Partnrs reaffirmed an “outperform” rating on shares of Cardinal Health in a research report on Monday, February 26th. Finally, StockNews.com lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday, April 24th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average target price of $102.93.
Check Out Our Latest Report on CAH
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
- Five stocks we like better than Cardinal Health
- The How and Why of Investing in Biotech Stocks
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Hilton Demonstrates Asset Light is Right for Investors
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.